Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20652Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tsivgoulis, G. | en |
| dc.contributor.author | Kotsis, V. | en |
| dc.contributor.author | Giannopoulos, S. | en |
| dc.date.accessioned | 2015-11-24T19:09:06Z | - |
| dc.date.available | 2015-11-24T19:09:06Z | - |
| dc.identifier.issn | 1747-4949 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20652 | - |
| dc.rights | Default Licence | - |
| dc.subject | Blood Pressure/*physiology | en |
| dc.subject | Clinical Trials as Topic | en |
| dc.subject | Fibrinolytic Agents/administration & dosage | en |
| dc.subject | Humans | en |
| dc.subject | *Hypertension/etiology/prevention & control | en |
| dc.subject | Injections, Intravenous | en |
| dc.subject | Practice Guidelines as Topic | en |
| dc.subject | Stroke/complications/*drug therapy | en |
| dc.subject | Thrombolytic Therapy/methods/*standards | en |
| dc.subject | Tissue Plasminogen Activator/administration & dosage | en |
| dc.title | Intravenous thrombolysis for acute ischaemic stroke: effective blood pressure control matters | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1111/j.1747-4949.2010.00570.x | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21371274 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1111/j.1747-4949.2010.00570.x/asset/j.1747-4949.2010.00570.x.pdf?v=1&t=h0al01dr&s=5fc591c2f3c5a66dc796189b4e40a17c7f15d13a | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | In this Leading opinion we summarise the observational evidence endorsing current guidelines that advocate effective blood pressure control before and during an rtPA infusion and indicate that a more active blood pressure-lowering approach immediately after intravenous thrombolysis appears to be a promising therapeutic option that should be formerly evaluated in a randomised clinical trial setting. Acute ischaemic stroke is a highly treatable neuroemergency and the efficacy of the available treatment is not only related to the speed by which it is administered but also by the effective control of modifiable adverse outcome predictors including elevated blood pressure levels. | en |
| heal.journalName | Int J Stroke | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Tsivgoulis-2011-Intravenous thrombol.pdf | 77.79 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
